College of Medicine Names Inaugural Vice Dean of Research

The University of Oklahoma College of Medicine is proud to announce the appointment of Carlos D. Bustamante, Ph.D., as the inaugural Vice Dean of Research, effective September 1, 2025, pending approval by the OU Board of Regents.

Dr. Bustamante is internationally recognized as one of the foremost experts in medical and population genetics. His groundbreaking research has significantly advanced scientific understanding of human genetic variation and its impact on health and disease. A MacArthur Fellow and a former professor at both Cornell and Stanford Universities, Dr. Bustamante also served as the founding Chair of the Department of Biomedical Data Science at Stanford. His leadership in the development of statistical methods continues to shape the fields of medical and evolutionary genomics.

Over the course of his distinguished career, Dr. Bustamante has played pivotal roles in major National Institutes of Health initiatives, including the 1000 Genomes Project and ClinGen, where he co-led efforts to standardize how genetic variants are interpreted in a clinical context. As a principal investigator with the National Human Genome Research Institute Genome Sequencing and Analysis Centers, he contributed to early advancements in sequencing technologies and genomic annotation. In addition to his research, Dr. Bustamante has led T32 training programs to mentor emerging scientists and has published more than 250 scientific papers, shaping the careers of hundreds of researchers.

Beyond academia, Dr. Bustamante is the founder and CEO of Galatea Bio, a venture-backed genomics company focused on developing scalable precision health technologies. His experience in both academic and industry settings positions him uniquely to foster impactful partnerships and drive innovation through public-private collaboration.

The creation of the Vice Dean of Research role marks a significant milestone in the OU College of Medicine’s deepening commitment to research and scholarship as a central pillar of our mission, said College of Medicine Executive Dean Ian Dunn, M.D., FACS, FAANS.

In this new capacity, Dr. Bustamante will collaborate closely with leaders across the College of Medicine, the OU Health Sciences, OU Health, and the OU Office of the Vice President for Research and Partnerships.

“His leadership will help expand the College’s research infrastructure, support faculty and trainee development, and elevate our impact in basic, translational, clinical, and health outcomes research,” Dunn said.